Back to search
FDAFDA · Food and drugs·Recall number D-0100-2023

Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06

Published January 18, 2023 · Recall initiated: December 12, 2022

Summary

FDA records drug Class II recall D-0100-2023, published January 18, 2023 and initiated December 12, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 16,056 30 count bottles; Lot: Lot # A200171, Exp 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.

What to do

Voluntary: Firm initiated · Letter

Get an email if RIFAMPIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
RIFAMPIN
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot # A200171, Exp 12/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06 recalled?

Yes. FDA published recall D-0100-2023 on January 18, 2023. Reported hazard: Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: RIFAMPIN.